White Matter Microstructure Changes in the Thalamus in Parkinson Disease with Depression: A Diffusion Tensor MR Imaging Study

References

1. 1.↵
   1. Cummings JL,
   2. Masterman DL

   . Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry 1999;14:711–18

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Shulman LM,
   2. Taback RL,
   3. Bean J,
   4. et al

   . Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001;16:507–10

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Remy P,
   2. Doder M,
   3. Lees A,
   4. et al

   . Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314–22

   Abstract/FREE Full Text
4. 4.↵
   1. Rodin G,
   2. Voshart K

   . Depression in the medically ill: an overview. Am J Psychiatry 1986;165:333–39
5. 5.↵
   1. Cardoso EF,
   2. Maia FM,
   3. Fregni F,
   4. et al

   . Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. Neuroimage 2009;47:467–72

   CrossRefPubMed
6. 6.↵
   1. Cole SA,
   2. Woodard JL,
   3. Juncos JL,
   4. et al

   . Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:20–25

   PubMedWeb of Science
7. 7.↵
   1. Burn DJ

   . Depression in Parkinson's disease. Eur J Neurol 2002;9:44–54

   CrossRefPubMedWeb of Science
8. 8.↵
   1. McDonald WM,
   2. Richard IH,
   3. Delong MR

   . Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003;54:363–75

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Price JL

   . Prefrontal cortical networks related to visceral function and mood. Ann NY Acad Sci 1999;877:383–96

   CrossRefPubMedWeb of Science
10. 10.↵
    1. LeDoux JE

    . Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155–84

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Young KA,
    2. Holcomb LA,
    3. Yazdani U,
    4. et al

    . Elevated neuron number in the limbic thalamus in major depression. Am J Psychiatry 2004;161:1270–77

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Phillips ML,
    2. Drevets WC,
    3. Rauch SL,
    4. et al

    . Neurobiology of emotion perception. I. The neural basis of normal emotion perception. Biol Psychiatry 2003;54:504–14

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Garcia-Cabezas MA,
    2. Rico B,
    3. Sanchez-Gonzalez MA,
    4. et al

    . Distribution of the dopamine innervation in the macaque and human thalamus. Neuroimage 2007;34:965–84

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Bremner JD,
    2. Vythilingam M,
    3. Ng CK,
    4. et al

    . Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA 2003;289:3125–34

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Carlson PJ,
    2. Singh JB,
    3. Zarate JCA,
    4. et al

    . Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 2006;3:22–41

    CrossRefPubMed
16. 16.↵
    1. Basser PJ,
    2. Mattiello J,
    3. LeBihan D

    . MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–67

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Pierpaoli C,
    2. Jezzard P,
    3. Basser PJ,
    4. et al

    . Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637–48

    PubMedWeb of Science
18. 18.↵
    1. LeBihan D,
    2. Mangin JF,
    3. Poupon C,
    4. et al

    . Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534–46

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Voss HU,
    2. Schiff ND

    . MRI of neuronal network structure, function, and plasticity. Prog Brain Res 2009;175:483–96

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Matsui H,
    2. Nishinaka K,
    3. Oda M,
    4. et al

    . Depression in Parkinson's disease: diffusion tensor imaging study. J Neurol 2007;254:1170–73

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Menke RA,
    2. Scholz J,
    3. Miller KL,
    4. et al

    . MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009;47:435–41. Epub 2009 May 15

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Lee DY,
    2. Fletcher E,
    3. Martinez O,
    4. et al

    . Regional pattern of white matter microstructural changes in normal aging: MCI and AD. Neurology 2009;73:1722–28. Epub 2009 Oct 21

    Abstract/FREE Full Text
23. 23.↵
    1. Mielke MM,
    2. Kozauer NA,
    3. Chan KC,
    4. et al

    . Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009;46:47–55

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Gattellaro G,
    2. Minati L,
    3. Grisoli M,
    4. et al

    . White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222–26

    Abstract/FREE Full Text
25. 25.↵
    1. Alexander AL,
    2. Lee JE,
    3. Lazar M,
    4. et al

    . Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316–29

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Song SK,
    2. Sun SW,
    3. Ramsbottom MJ,
    4. et al

    . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Alexopoulos GS,
    2. Kelly RE Jr.

    . Research advances in geriatric depression. World Psychiatry 2009;8:140–09

    PubMedWeb of Science
28. 28.↵
    1. Alexopoulos GS,
    2. Murphy CF,
    3. Gunning-Dixon FM,
    4. et al

    . Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. J Affect Disord 2009;119:132–41. Epub 2009 Apr 17

    CrossRefPubMed
29. 29.↵
    1. Hughes AJ,
    2. Daniel SE,
    3. Kilford L,
    4. et al

    . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–84

    Abstract/FREE Full Text
30. 30.↵
    1. Scanlon BK,
    2. Katzen HL,
    3. Levin BE,
    4. et al

    . A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage. Parkinsonism Relat Disord 2008;14:379–80. Epub 2007 Nov 19

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Kohn R,
    2. Vicente B,
    3. Rioseco P,
    4. et al

    . The Mini-Mental State Examination: age and education distribution for a Latin American population. Aging Ment Health 2008;12:66–71

    CrossRefPubMed
32. 32.↵
    1. Ravina B,
    2. Marder K,
    3. Fernandez HH,
    4. et al

    . Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007;22:1061–68

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Cohen SD,
    2. Norris L,
    3. Acquaviva K,
    4. et al

    . Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2007;2:1332–42

    Abstract/FREE Full Text
34. 34.↵
    1. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:208–19

    CrossRef
36. 36.↵
    1. Westin CF,
    2. Maier SE,
    3. Mamata H

    . Processing and visualization for diffusion tensor MRI. Med Image Anal 2002;6:93–108

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Karagulle Kendi AT,
    2. Lehericy S,
    3. Luciana M,
    4. et al

    . Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008;29:501–05

    Abstract/FREE Full Text
39. 39.↵
    1. Scherfler C,
    2. Schocke MF,
    3. Seppi K,
    4. et al

    . Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006;129:538–42

    Abstract/FREE Full Text